Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
Joshua D. Bernstock(Brigham and Women's Hospital), John M. Hallenbeck(National Institutes of Health)
Cited by 41
Related Papers
Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.
|Stroke|1992|620
Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
|Journal of Cerebral Blood Flow & Metabolism|2012|307
Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
|Proceedings of the National Academy of Sciences|1997|156
Global, Regional, and National Economic Consequences of Stroke
|Stroke|2023|137